By Jill Redhage
Daily Journal Staff Writer
Latham & Watkins represented Aliso Viejo-based Clarient Inc., a molecular diagnostics company, in its $580 million sale to GE Healthcare. The combination is meant to speed the development of tools for diagnosing cancer. The companies expect the deal to close in late 2010 or early 2011. Los Angeles corporate partner W. Alex Voxman and Costa Mesa corporate partner R. Scott Shean led the legal team...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In